At low concentrations, TGFβ acts as a chemoattractant that attracts fibroblasts to the tumor site and, at higher concentrations, it induces fibroblasts to transdifferentiate into myofibroblasts, which are classified as CAFs [46,47]. This evidence concerns the gene TGFB1 and neoplasm.